Lindbrook Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $6.58K | Buy |
629
+410
| +187% | +$4.29K | ﹤0.01% | 1843 |
|
2024
Q4 | $5.16K | Sell |
219
-105
| -32% | -$2.47K | ﹤0.01% | 1973 |
|
2024
Q3 | $11.6K | Hold |
324
| – | – | ﹤0.01% | 1585 |
|
2024
Q2 | $11.4K | Buy |
324
+183
| +130% | +$6.46K | ﹤0.01% | 1555 |
|
2024
Q1 | $4K | Hold |
141
| – | – | ﹤0.01% | 1996 |
|
2023
Q4 | $1.88K | Buy |
141
+5
| +4% | +$66 | ﹤0.01% | 2284 |
|
2023
Q3 | $1.22K | Buy |
136
+33
| +32% | +$296 | ﹤0.01% | 2296 |
|
2023
Q2 | $1.16K | Sell |
103
-117
| -53% | -$1.32K | ﹤0.01% | 2338 |
|
2023
Q1 | $2.53K | Buy |
220
+117
| +114% | +$1.35K | ﹤0.01% | 2145 |
|
2022
Q4 | $1.19K | Sell |
103
-84
| -45% | -$974 | ﹤0.01% | 2421 |
|
2022
Q3 | $2K | Buy |
+187
| New | +$2K | ﹤0.01% | 2036 |
|
2022
Q2 | – | Sell |
-437
| Closed | -$4K | – | 2559 |
|
2022
Q1 | $4K | Buy |
+437
| New | +$4K | ﹤0.01% | 1685 |
|